TABLE 2.
Primer function and name | Nucleotide sequence (5′-3′)a | Source or reference |
---|---|---|
Construction of plasmids for allelic replacement | ||
agr.upF | ATTTA GAATTC ATATGAATGCTGAAGTAGAT | This study |
agr.upR | ATTAA GGATCC GTTATCTTCGTATAGTACTA | This study |
agr.downF | ATTTA CTGCAG TTCAATTGTAAATCTTGTTG | This study |
agr.downR | AATAT AAGCTT TTGATACATCTAGTATAGAA | This study |
sarA.upF | ATTTA GAATTC GAGACTTTATTCATATGCTT | This study |
sarA.upR | ATTTA GGATCC CTTAAGAATGAGTTGACTAT | This study |
sarA.downF | ATTTA CTGCAG TGATAGATGATACATTCTAT | This study |
sarA.downR | ATTAT AAGCTT TTATCTTCACGTACAAGATT | This study |
Primer extension | ||
spa.PEbio1 | BIO-TGTTACGCCACCAGATATAA | This study |
spa.PEbio3 | BIO-ACCTAGTTTACGAATTGAATA | This study |
Amplification of DIG-labeled probes | ||
SA1665F | TTCGTATAGAGGCTGGTTAG | 23 |
SA1665R | AATTGGTTGGTTATCTGGAT | 23 |
spaF | TGTAGGTATTGCATCTGTAA | 52 |
spaR | AAGTTAGGCATATTCAAGAT | 52 |
sarSF | TTGATGAGCGTAATACTTAC | 52 |
sarSR | GAGCTAATAATTGTTCAGCA | 52 |
RNAIII.F | TATAACTAGATCACAGAGATG | This study |
RNAIII.R | TTAGTACTATACGAAGATAAC | This study |
sarA.F3 | TATTGACATACATCAGCGAA | This study |
sarA.R1 | GTTTGCTTCAGTGATTCGTT | This study |
fadXF | TAGCGAATGATATTCATAGT | This study |
fadXR | TAGTTGATAGTCGTCAACTA | This study |
SAR0995F | ATCATTGAACGCTCTTGCAA | This study |
SAR0995R | ATAGCGTGTCAATGCTTCAA | This study |
SAR0996F | CTAATGTTAAACATACAACT | This study |
SAR0996R | TATTCTGCCGTATATTGATT | This study |
SAR1741F | GTATGAATTAATGCCGATTA | This study |
SAR1741R | CGTCACCATAACCAATATAT | This study |
SAR2413F | CAACGCTTACAAGGCTATAA | This study |
SAR2413R | GCTACACAGTTCACTCTAAT | This study |
SAR2589F | GGTTATGCATTAATGCAAGT | This study |
SAR2589R | TAACGTGGAATACTTCTGTT | This study |
mtlAF | CCAATGTTACTTGGTGCAAT | This study |
mtlAR | TAAGTTGCAACACCAGTCAT | This study |
sarT-U.F | GATTGGTCTATACCGATATA | This study |
sarT-U.R | GTTGTATTGGAGTAACTGAA | This study |
Amplification of spa promoter fragments for lacZ reporter gene constructs | ||
spa.lacZF1 | AATTT GGATCC GAATCAATTATTAGCAGATAA | This study |
spa.lacZF2 | AATTT GGATCC TCAGCACATAATGAACAACTT | This study |
spa.lacZF3 | AATTT GGATCC TGTATTAAACCGCTTTCATTA | This study |
spa.lacZF4 | AATTT GGATCC ACTTCCTGAATAAATCTTTCA | This study |
spa.lacZF5 | AATTT GGATCC AAATATCTCTATATTTTATC | This study |
spa.lacZF6 | AATTT GGATCC TATTAATCGAAATAGCGTGA | This study |
spa.lacZF7 | AATTT GGATCC TTATAAGTTGTAAAACTTAC | This study |
spa.lacZF8 | AATTT GGATCC AATATAGATTTTAGTATTGC | This study |
spa.lacZF9 | AATTT GGATCC GTATTGCAATACATAATTCG | This study |
spa.lacZR | AATTT GAATTC ACCTAGTTTACGAATTGAATA | This study |
Restriction sites are underlined; BIO denotes 5′ biotinylation.